Natick, MA, United States of America

Sharmila Adhikari

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Millennium Pharmaceuticals Limited. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sharmila Adhikari. Retrieved from https://idiyas.com/inventor/sharmila-adhikari

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Certainly! Here is the article about inventor Sharmila Adhikari:

Title: The Innovative Inventor - Sharmila Adhikari

Introduction:

Sharmila Adhikari is a talented inventor based in Natick, MA. With a keen focus on pharmaceutical innovation, he has made significant contributions to the field through his groundbreaking work.

Latest Patents:

Sharmila Adhikari holds one patent for ATG7 inhibitors and their uses, which are chemical compounds designed to inhibit ATG7. These compounds have shown potential in the treatment of cancer, offering new hope for patients in need.

Career Highlights:

Currently working at Millennium Pharmaceuticals Limited, Sharmila Adhikari has brought his expertise to the forefront of pharmaceutical research. His dedication to developing novel solutions for complex medical challenges has earned him recognition in the industry.

Collaborations:

Sharmila Adhikari has collaborated with esteemed professionals in the field, including Emily Frances Calderwood and Dylan Bradley England. Together, they have worked on cutting-edge projects that push the boundaries of pharmaceutical innovation.

Conclusion:

Inventor Sharmila Adhikari's commitment to advancing healthcare through his inventive solutions is truly commendable. His work serves as a testament to the power of innovation in improving the lives of individuals worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…